Atlas Trials

EGFR T790M

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch EGFR T790M

RecordFirmDate
Evaluation of Clinical Performance and IVD Test of LifeOS Digital PCR Liquid Biopsy Kits for EGFR T790M Mutation (NCT06573073)LifeOS Genomics Corporation2024-09-06
Lazertinib 160mg in EGFR T790M NSCLC (NCT05701384)Samsung Medical Center2023-02-01
Lazertinib Real-world Observational Study of in Pre-treated EGFR T790M Mutant With Advanced Non-small Cell Lung Cancer (NCT05377788)Samsung Medical Center2022-07-31
(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC (NCT04862780)Blueprint Medicines Corporation2021-06-29
Almonertinib/Pemetrexed/Carboplatin in EGFR T790M+ Advanced Lung Cancer (NCT04592666)Fudan University2020-10-09
Correlation Between Efficacy of Osimertinib and EGFR T790M Status and Ratio Via ddPCR in NSCLC (NCT05458726)Peking Union Medical College2020-09-15
Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC) (NCT03532698)Daping Hospital and the Research Institute of Surgery of the Third Military Medical University2020-08-01
Exploring the Theragnostic Value of Osimertinib in EGFR-mutated Lung Cancer (THEROS) (NCT03810066)University Hospital, Essen2019-06-03
D-0316 in Patients With EGFR Positive Non Small Cell Lung Cancer (NCT03861156)InventisBio Co., Ltd2019-02-28
Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC (NCT03543683)Daping Hospital and the Research Institute of Surgery of the Third Military Medical University2018-01-01

Track EGFR T790M automatically

Every clearance here is in the API, with alerts when new ones post.